Phase 1b norovirus challenge study is underway at Emory University School of MedicineCDI-988 is the first oral antiviral ...
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across ...
EXTON, Pa., Jan. 30, 2026 /PRNewswire/ -- Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the expansion of its ...
Drug discovery has long been defined by time, cost, and repeated failure. Medvolt AI is using OpenAI-enabled intelligence to ...
A day after surpassing its own expectations with dazzling Phase III data for its lead pipeline candidate, the oral ulcerative colitis (UC) drug obefazimod, Abivax (Euronext Paris and NASDAQ: ABVX) so ...
Bissan Al-Lazikani (left) is a Professor of Genomic Medicine and Director of Therapeutics Data Science at The University of Texas MD Anderson Cancer Center (Houston, TX, USA), where she heads an ...
Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing activity to abnormal levels. Up is down and down is up. The right molecule ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results